Hab-o Shefa, a Persian Medicine Compound for Maintenance Treatment of Opioid Dependence: Randomized Placebo-Controlled Clinical Trial. Moosavyzadeh A, Mokri A, Ghaffari F, Faghihzadeh S, Azizi H, Jafari Hajati R, Naseri M. J Altern Complement Med…

Initiation of injectable opioid agonist treatment in hospital: A case report. McAdam M, Brar R, Young S. Drug Alcohol Rev. 2019 Dec 9. doi: 10.1111/dar.13020. Abstract https://www.ncbi.nlm.nih.gov/pubmed/31814186

Opioid use disorder and treatment: challenges and opportunities. Hoffman KA, Ponce Terashima J, McCarty D. BMC Health Serv Res. 2019 Nov 25;19(1):884. doi: 10.1186/s12913-019-4751-4.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876068/

Adjunctive memantine for opioid use disorder treatment: A systematic review. Elias AM, Pepin MJ, Brown JN. J Subst Abuse Treat. 2019 Dec;107:38-43. doi: 10.1016/j.jsat.2019.10.003. https://www.ncbi.nlm.nih.gov/pubmed/31757263

Fentanyl assisted treatment: a possible role in the opioid overdose epidemic? Bardwell G, Wood E, Brar R. Subst Abuse Treat Prev Policy. 2019 Nov 11;14(1):50. doi: 10.1186/s13011-019-0241-2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849248/

Sustained-release Oral Hydromorphone for the Treatment of Opioid Use Disorder. Braithwaite V, Fairgrieve C, Nolan S. J Addict Med. 2019 Oct 25. doi: 10.1097/ADM.0000000000000585.  Abstract https://www.ncbi.nlm.nih.gov/pubmed/31658114